Jerome D. Goldberg

Array ( [id] => 3429157 [patent_doc_number] => 05455249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-03 [patent_title] => 'Phosphorylcarbamates of rapamycin and oxime derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/327335 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5137 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 619 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/455/05455249.pdf [firstpage_image] =>[orig_patent_app_number] => 327335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220649 [patent_doc_number] => 06040334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy' [patent_app_type] => 1 [patent_app_number] => 8/330865 [patent_app_country] => US [patent_app_date] => 1994-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4135 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040334.pdf [firstpage_image] =>[orig_patent_app_number] => 330865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622091 [patent_doc_number] => 05593965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Anti-tumor effects of GnRH-III' [patent_app_type] => 1 [patent_app_number] => 8/326710 [patent_app_country] => US [patent_app_date] => 1994-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3025 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593965.pdf [firstpage_image] =>[orig_patent_app_number] => 326710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3592587 [patent_doc_number] => 05521191 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Method for treatment of arterial stenosis' [patent_app_type] => 1 [patent_app_number] => 8/324816 [patent_app_country] => US [patent_app_date] => 1994-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 3433 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/521/05521191.pdf [firstpage_image] =>[orig_patent_app_number] => 324816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3417419 [patent_doc_number] => 05453444 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-26 [patent_title] => 'Method to mitigate or eliminate weight loss' [patent_app_type] => 1 [patent_app_number] => 8/319081 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4692 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/453/05453444.pdf [firstpage_image] =>[orig_patent_app_number] => 319081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689328 [patent_doc_number] => 05643966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => '.beta.-alethine as anti-tumor agent' [patent_app_type] => 1 [patent_app_number] => 8/316836 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5706 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643966.pdf [firstpage_image] =>[orig_patent_app_number] => 316836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761839 [patent_doc_number] => 05843964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Methods of inhibiting endometrial mitoses' [patent_app_type] => 1 [patent_app_number] => 8/310292 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4261 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843964.pdf [firstpage_image] =>[orig_patent_app_number] => 310292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621149 [patent_doc_number] => 05614529 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Inhibition of plasmodia parasites by camptothecin compounds' [patent_app_type] => 1 [patent_app_number] => 8/309467 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4243 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 647 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614529.pdf [firstpage_image] =>[orig_patent_app_number] => 309467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3483062 [patent_doc_number] => 05446048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-29 [patent_title] => 'Rapamycin oximes' [patent_app_type] => 1 [patent_app_number] => 8/309816 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6664 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 508 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/446/05446048.pdf [firstpage_image] =>[orig_patent_app_number] => 309816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658284 [patent_doc_number] => 05658931 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds' [patent_app_type] => 1 [patent_app_number] => 8/309299 [patent_app_country] => US [patent_app_date] => 1994-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18198 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658931.pdf [firstpage_image] =>[orig_patent_app_number] => 309299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3544898 [patent_doc_number] => 05554628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs' [patent_app_type] => 1 [patent_app_number] => 8/308904 [patent_app_country] => US [patent_app_date] => 1994-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17617 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554628.pdf [firstpage_image] =>[orig_patent_app_number] => 308904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3715981 [patent_doc_number] => 05616588 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Rapamycin formulation for IV injection' [patent_app_type] => 1 [patent_app_number] => 8/302190 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2474 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616588.pdf [firstpage_image] =>[orig_patent_app_number] => 302190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624154 [patent_doc_number] => 05602170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Medicinal thiophene compounds' [patent_app_type] => 1 [patent_app_number] => 8/302278 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24599 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 363 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602170.pdf [firstpage_image] =>[orig_patent_app_number] => 302278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3583234 [patent_doc_number] => 05552154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/301727 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 6160 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552154.pdf [firstpage_image] =>[orig_patent_app_number] => 301727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775663 [patent_doc_number] => 05817667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Compounds and methods for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/301298 [patent_app_country] => US [patent_app_date] => 1994-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8083 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817667.pdf [firstpage_image] =>[orig_patent_app_number] => 301298 [rel_patent_id] =>[rel_patent_doc_number] =>)